Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (opent nieuw venster)

Ball AM, Winstead PS.

Bron‎: Pharmacotherapy 2008;28(11):1383-90.

Geïndexeerd‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (opent nieuw venster)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (opent nieuw venster)

Charles A, Purtill M, Napolitano LM.

Bron‎: Anaesth Intensive Care 2006;34(6):793-6.

Geïndexeerd‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (opent nieuw venster)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (opent nieuw venster)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Bron‎: N Engl J Med. 2023 2;389(18):1649-59.

Geïndexeerd‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (opent nieuw venster)

Bloodless management of the anemic patient in the emergency department. (opent nieuw venster)

Johnson-Arbor K, Verstraete R

Bron‎: Ann Emerg Med 2022;79(1):48-57.

Geïndexeerd‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (opent nieuw venster)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (opent nieuw venster)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Bron‎: J Trauma 2008;65(2):285-97.

Geïndexeerd‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (opent nieuw venster)

Erythropoiesis in multiply injured patients. (opent nieuw venster)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Bron‎: J Trauma 2006;61(5):1285-91.

Geïndexeerd‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (opent nieuw venster)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (opent nieuw venster)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Bron‎: Arch Surg 2012;147(3):251-5.

Geïndexeerd‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (opent nieuw venster)

Zeugen Jehovas und Schwerverletzung mit drohender Hämorrhagie. Wie komplex ist die Behandlung? [Jehovah's Witnesses and severe injury with impending hemorrhaging: how complex is the treatment?] [German, English abstract] (opent nieuw venster)

Zeckey C, Vanin N, Neitzke G, Mommsen P, Bachmann S, Frink M, Wilhelmi M, Krettek C, Hildebrand F.

Bron‎: Chirurg 2011;82(6):531-5.

Geïndexeerd‎: PubMed 21088815

DOI‎: 10.1007/s00104-010-1999-y

https://www.ncbi.nlm.nih.gov/pubmed/21088815 (opent nieuw venster)